| Structure |
Chemical Name |
CAS |
MF |
 |
1-chloro-8-phenyl-Dibenzofuran |
2379717-75-4 |
C18H11ClO |
![2-[4-[(1-methoxycarbonyl-2-oxocyclopentyl)methyl]phenyl]propanoic acid](/) |
2-[4-[(1-methoxycarbonyl-2-oxocyclopentyl)methyl]phenyl]propanoic acid |
|
|
 |
3,20-bis(ethylenedioxy)pregna-5,7-diene |
19592-55-3 |
C25H36O4 |
 |
Isopropyl 2-((5-amino-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyphenyl)amino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate |
1847465-25-1 |
C29H37N7O3 |
 |
7-amino-3-phenyl-2-benzopyrone |
4108-61-6 |
C15H11NO2 |
 |
methyl ibogamine-18-carboxylate |
467-77-6 |
C21H26N2O2 |
 |
4-Methylcumarin |
607-71-6 |
C10H8O2 |
 |
Dabigatran intermediate |
|
|
 |
1,1-Dimethylethyl 10,10-dimethyl-8-oxo-3,9-dioxa-2,7-diazaundecanoate |
1243021-74-0 |
C13H26N2O5 |
 |
ethyl 8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydroquinoline-4-oxo-3-carboxyla |
99696-21-6 |
C15H12ClF2NO3 |
 |
2'-DEOXYCYTIDINE MONOHYDRATE, 99+% |
652157-52-3 |
C9H15N3O5 |
 |
tert-butyl (3R,6S)-3-((tert-butoxycarbonyl)((tert-butyldimethylsilyl)oxy)amino) -6-carbamoyl -5-methyl-3,6-dihydropyridine-1(2H)-carboxylate |
2209874-00-8 |
C23H43N3O6Si |
 |
5-Pyrimidinamine, 2-nitro- (9CI) |
123770-64-9 |
C4H4N4O2 |
![(3S)-3-(Boc-amino)-2-hydroxy-4-[(S)-2-oxo-3-pyrrolidinyl]butanenitrile](/CAS/20211123/GIF/2755780-15-3.gif) |
(3S)-3-(Boc-amino)-2-hydroxy-4-[(S)-2-oxo-3-pyrrolidinyl]butanenitrile |
2755780-15-3 |
C13H21N3O4 |
![1-acetyl-3-[((2r)-1-methylpyrrolidin-2-yl)methyl]-5-[(e)-2-(phenylsulfonyl)vinyl]indole](/CAS/GIF/188113-71-5.gif) |
1-acetyl-3-[((2r)-1-methylpyrrolidin-2-yl)methyl]-5-[(e)-2-(phenylsulfonyl)vinyl]indole |
188113-71-5 |
C24H26N2O3S |
 |
5'-Methoxylaudanosine |
24734-71-2 |
C22H29NO5 |
 |
8-Benzyloxy-5-((R)-2-broMo-1-hydroxyethyl)-1H-quinolinone |
530084-79-8 |
C18H16BrNO3 |
![(R)-5,9-Bis(3,5-bis(trifluoromethyl)phenyl)-7-hydroxy-14,15,16,17-tetrahydrodiphenaleno[1,9-de:1',9'-fg][1,3,2]dioxaphosphocine 7-oxide](/CAS/20250703/GIF/2695533-33-4.gif) |
(R)-5,9-Bis(3,5-bis(trifluoromethyl)phenyl)-7-hydroxy-14,15,16,17-tetrahydrodiphenaleno[1,9-de:1',9'-fg][1,3,2]dioxaphosphocine 7-oxide |
2695533-33-4 |
C41H23F12O4P |
 |
1375471-12-7 |
1375471-12-7 |
C19H22F6N2O3 |
 |
Ibrexafungerp Intermediate |
1140751-11-6 |
C31H50O5 |
 |
Ceftiofur Double Mother Nucleus |
|
|
 |
Cefixime Dimer D |
|
|
 |
7S-Cephalexin |
|
|
 |
(6R,7S)-Latamoxef MotherNucleus |
|
|
 |
COUMARIN 6 |
88241-65-0 |
C15H12O2 |
 |
5-Bromopentan-1-ol |
34626-51-2 |
C5H11BrO |
 |
FLUTICASONE PROPIONATE INTERMEDIATE |
80474-45-9 |
C24H30F2O5S |
 |
2-Chloro-5-methylpyrazine |
59303-10-5 |
C5H5ClN2 |
 |
2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol |
142569-70-8 |
C29H28ClNO2 |
 |
1,3-Benzodioxole-5-acetic acid methyl ester |
326-59-0 |
C10H10O4 |
![1H-Indole-2-carboxamide, 1-[(1S,2S)-1-cyano-2-methylcyclopropyl]-N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-](/CAS/20210305/GIF/2212021-81-1.gif) |
1H-Indole-2-carboxamide, 1-[(1S,2S)-1-cyano-2-methylcyclopropyl]-N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]- |
2212021-81-1 |
C28H31N3O2 |
 |
cytidylyl-(5'->3')-guanosine |
4785-04-0 |
C19H25N8O12P |
![(6R-trans)-3-(acetoxymethyl)-7-[(2-aminothiazol-4-yl)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid](/CAS/GIF/58233-18-4.gif) |
(6R-trans)-3-(acetoxymethyl)-7-[(2-aminothiazol-4-yl)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
58233-18-4 |
C15H16N4O6S2 |
 |
5,5'-methylenebis(1H-benzotriazole) |
15805-10-4 |
C13H10N6 |
 |
4-(dimethylammonio)piperidinium dichloride |
4876-59-9 |
C7H18Cl2N2 |
 |
Dolutegravir intermediate |
|
|
 |
(7S)-Cefuroxime |
|
|
 |
5-phenyl-2,3,7-tris(phenylamino)phenazinium chloride |
4935-81-3 |
C36H28ClN5 |
 |
4-chloro-1-(dichloromethyl)benzene |
13940-94-8 |
C7H5Cl3 |
 |
1(2H)-Pyridinecarboxylic acid, 2-(aminocarbonyl)-3,6-dihydro-3-methyl-, 1,1-dimethylethyl ester, (2S,3R)- |
2209874-09-7 |
C12H20N2O3 |
 |
6-Methyleneandrost-4-ene-3,17-dione |
19457-55-7 |
C20H26O2 |
 |
Prostaglandin F3a |
|
|
 |
8-iso Prostaglandin F2a-d4 |
|
|
 |
6,7-DIHYDROXY-4-(TRIFLUOROMETHYL)COUMARIN |
82747-36-2 |
C10H5F3O4 |
 |
455284-06-7 |
455284-06-7 |
|
 |
N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide |
122584-18-3 |
C17H18BrNO4 |
 |
4-Chlorodehydromethyltestosterone |
2446-23-3 |
C20H27ClO2 |
 |
2'-iodo-2'-deoxyuridine |
4753-03-1 |
C9H11IN2O5 |
 |
HEMATOPORPHYRIN |
14459-29-1 |
C34H38N4O6 |
![(1S,2R,3S,5R)-3-(Phenymethyloxy)-2-(phenylmethoxy)methyl-6-oxabicyclo[3.1.0]hexane](/CAS/20180808/GIF/110567-22-1.gif) |
(1S,2R,3S,5R)-3-(Phenymethyloxy)-2-(phenylmethoxy)methyl-6-oxabicyclo[3.1.0]hexane |
110567-22-1 |
C20H22O3 |
 |
tert-Butyl (1-(hydroxymethyl)cyclopropyl)carbamate |
107017-73-2 |
C9H17NO3 |
 |
Bis(vinylsulfonylmethyl) ether |
26750-50-5 |
C6H10O5S2 |
 |
Orlistat pellets |
|
|
 |
3-Des(1-ethylpropoxy)-3-(1-Methylpropoxy) OseltaMivir |
1052063-37-2 |
C15H26N2O4 |
 |
(9H-fluoren-9-yl)methyl N-(carbamoylmethyl)carbamate |
115057-37-9 |
C17H16N2O3 |
 |
Inosine API manufacturers |
|
|
 |
3’-deoxyinosine |
|
|
 |
Acetoxy Ceftazidime Intermediate |
|
|
 |
Flomoxef Intermediate FXMT |
|
|
 |
4-METHYL 6-HYDROXY 7-ACETOXY COUMARIN |
46895-13-0 |
C12H10O6 |
 |
Pyrazole |
288-13-1 |
C3H4N2 |
 |
9-OXO-11ALPHA,15S-DIHYDROXY-PROST-13E-EN-1-OIC-3,3,4,4-D4 ACID |
211105-33-8 |
C20H30D4O5 |
 |
7,10-Dioxa-2,5-diazaundecanoic acid, 4,9-dioxo-11-phenyl-, 9H-fluoren-9-ylmethyl ester |
1599440-07-9 |
C27H26N2O6 |
![2,3,5,6-1H,4H-TETRAHYDROQUINOLIZINO[9,9A,1-GH]COUMARIN](/CAS/GIF/58336-35-9.gif) |
2,3,5,6-1H,4H-TETRAHYDROQUINOLIZINO[9,9A,1-GH]COUMARIN |
58336-35-9 |
C15H15NO2 |
 |
3-Fluorobenzylamine |
100-82-3 |
C7H8FN |
 |
(3R,4R,5R)-Oseltamivir |
|
|
 |
4-Piperidinecarboxylic acid, 3-methyl-4-phenyl-, phenylmethyl ester, (3S,4R)- |
2357209-42-6 |
C20H23NO2 |
![(1R)-7-Chloro-6-fluoro-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione](/CAS/20211123/GIF/2300966-23-6.gif) |
(1R)-7-Chloro-6-fluoro-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione |
2300966-23-6 |
C16H14ClFN4O2 |
 |
(9H-fluoren-9-yl)methyl (R)-(3-(2-bromophenyl)-1-(methylamino)-1-oxopropan-2-yl)carbamate |
|
|
![Spiro[6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-20,1'-[1H]pyrido[3,4-b]indole]-14-carbonitrile, 5-(acetyloxy)-2',3',4',6,6a,7,9',13,14,16-decahydro-8-hydroxy-6',9-dimethoxy-4,10,23-trimethyl-19-oxo-, (1'R,6R,6aR,7R,13S,14R,16R)- (9CI)](/CAS/20211123/GIF/497871-10-0.gif) |
Spiro[6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-20,1'-[1H]pyrido[3,4-b]indole]-14-carbonitrile, 5-(acetyloxy)-2',3',4',6,6a,7,9',13,14,16-decahydro-8-hydroxy-6',9-dimethoxy-4,10,23-trimethyl-19-oxo-, (1'R,6R,6aR,7R,13S,14R,16R)- (9CI) |
497871-10-0 |
C42H43N5O9S |
 |
2',3'-Didehydro-2',3'-dideoxy-5'-acetate inosine |
130676-57-2 |
C12H12N4O4 |
 |
(R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone |
101328-85-2 |
C11H13N3O |
 |
α-L-Idopyranoside, 4-methylphenyl 4,6-O-(1-methylethylidene)-3-O-(phenylmethyl)-1-thio- |
2234242-37-4 |
C23H28O5S |
 |
2-(2-pyridyl)isothiourea N-oxide hydrochloride |
2770-93-6 |
C6H8ClN3OS |
 |
disodium tetrabromophthalate |
25357-79-3 |
C8Br4Na2O4 |
 |
(+)-Camphor Bromide |
10293-06-8 |
C10H15BrO |
 |
Perfluoro(4-methyl-3,6-dioxaoct-7-ene)sulfonyl fluoride |
16090-14-5 |
C7F14O4S |
 |
7-METHOXY-4-(TRIFLUOROMETHYL)COUMARIN |
575-04-2 |
C11H7F3O3 |
 |
7-ANCA Hydroxyl Double-Bond Reduction Impurity |
|
|
 |
β-NADPH-D |
74784-45-5 |
C21H30N7O17P3 |
 |
Tert-Butyl 4-Vinylphenyl Carbonate |
87188-51-0 |
C13H16O3 |
![4-[3-(Trifluoromethyl)phenyl]-1-piperazineethanol](/CAS/GIF/40004-29-3.gif) |
4-[3-(Trifluoromethyl)phenyl]-1-piperazineethanol |
40004-29-3 |
C13H17F3N2O |
![1H-ISOINDOLE-1,3(2H)-DIONE, 2-[[(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-5-OXAZOLIDINYL]METHYL]-](/CAS/GIF/446292-08-6.gif) |
1H-ISOINDOLE-1,3(2H)-DIONE, 2-[[(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-5-OXAZOLIDINYL]METHYL]- |
446292-08-6 |
C22H19N3O6 |
 |
3-Iodo-1H-pyrazole |
4522-35-4 |
C3H3IN2 |
![1-Azepanyl(4,5,6,7-tetrahydro-1H-pyrazolo-[4,3-c]pyridin-3-yl)methanone hydrochloride](/CAS/GIF/1219982-46-3.gif) |
1-Azepanyl(4,5,6,7-tetrahydro-1H-pyrazolo-[4,3-c]pyridin-3-yl)methanone hydrochloride |
1219982-46-3 |
C13H21ClN4O |
 |
Diisopropyl 3,3-dimethoxycyclobutane-1,1-dicarboxylate |
115118-68-8 |
C14H24O6 |
 |
Win-1161-3 |
60662-79-5 |
C20H28ClNO2S |
![6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole](/CAS/GIF/1231930-33-8.gif) |
6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole |
1231930-33-8 |
C11H12BrFN2 |
 |
5ß-Pregnan-3ß,6a,20ß-Triol-6a-O-ß-D-Glucuronide |
|
|
 |
Des-(N-methyl-5-tetrazolethiolyl)furolactone Cefoperazone |
73240-08-1 |
C23H23N5O8S |
 |
(5α,10α)-5,10-Epoxy-estr-9(11)-ene-3,17-dione Cyclic 3-(1,2-Ethanediyl Acetal) |
39931-87-8 |
C20H26O4 |
 |
Methyl 5-chloro-6-methylpyrazine-2-carboxylate |
77168-85-5 |
C7H7ClN2O2 |
![N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester](/CAS/GIF/1334513-02-8.gif) |
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester |
1334513-02-8 |
C18H17F5NO5P |
 |
isopropylideneaMinooxyethanol |
83495-51-6 |
C5H11NO2 |
![(4aS,7aS)-octahydropyrrolo[3,4-b][1,4]oxazine](/CAS/20150408/GIF/209401-69-4.gif) |
(4aS,7aS)-octahydropyrrolo[3,4-b][1,4]oxazine |
209401-69-4 |
C6H12N2O |
![Propanoic acid, 3-[(1S)-1-[(1S,3aS,4E,7aS)-4-[(2Z)-[(3S,5R)-3,5-bis[[(1,1-diMethylethyl)diMethylsilyl]oxy]-2-Methylenecyclohexylidene]ethylidene]octahydro-7a-Methyl-1H-inden-1-yl]ethoxy]-, ethyl este](/CAS/20200515/GIF/413571-27-4.gif) |
Propanoic acid, 3-[(1S)-1-[(1S,3aS,4E,7aS)-4-[(2Z)-[(3S,5R)-3,5-bis[[(1,1-diMethylethyl)diMethylsilyl]oxy]-2-Methylenecyclohexylidene]ethylidene]octahydro-7a-Methyl-1H-inden-1-yl]ethoxy]-, ethyl este |
413571-27-4 |
C38H68O5Si2 |
 |
1-Acetyl-4-(4-hydroxyphenyl)piperazine side chain of Ketoconazole |
67914-99-2 |
C13H18N2O3 |
 |
(R)-Levofloxacin |
|
C18H20FN3O4 |
 |
Piperazine, 1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)- (acetate) |
906093-30-9 |
C16H22N4O2 |
 |
FMoc-Val-Cit-PAB-PNP |
863971-53-3 |
C40H42N6O10 |